Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Ceva Sante Animale launches heart failure therapy for dogs

Ceva Sante Animale launches heart failure therapy for dogs

24th September 2012

Ceva Sante Animale has launched Cardalis, a canine heart failure treatment that combines two proven active ingredients.

The unique therapy combines benazepril and spironolactone into a single easy-to-administer tablet, thus helping to greatly improve owner compliance when compared to dual-tablet regimens.

Studies have shown that taking an angiotensin converting enzyme inhibitor (ACEi) alongside an aldosterone receptor blocker delivers health benefits compared to an ACEi alone among both humans and dogs.

Moreover, it has been shown that 86.5 percent of dog owners were compliant with Cardalis treatments during a three-month trial period, whereas more than 25 percent failed to comply a two-tablet treatment just two weeks after prescribing.

The drug will be launched in most European countries over the autumn and will make it easier and more cost-effective than ever to treat canine heart conditions.

Last month, Ceva Sante Animale announced the launch of the Perfect Pair, a new vaccine product for poultry producers that offers dual protection against Newcastle disease and infectious bursal disease.ADNFCR-8000103-ID-801455592-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.